Antiseizure medication prescribing in people with Dravet syndrome: An analysis of real‐time administrative data

Antiseizure medication prescribing in people with Dravet syndrome: An analysis of real‐time administrative data

Abstract Since 2018, three new antiseizure medications (ASMs) received FDA approval for Dravet syndrome (DS) in the U.S: cannabidiol, stiripentol, and fenfluramine. Yet, the uptake of these ASMs in routine clinical practice is unknown. We use new ICD‐10 codes for DS (implemented in 2020) to estimate...

Full description

Saved in:
Bibliographic Details
Main Authors: Kevin Y. Xu, Binx Yezhe Lin, M. Scott Perry, Fábio A. Nascimento
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Epilepsia Open
Subjects:
administrative data
antiseizure medication
cannabidiol
Dravet syndrome
fenfluramine
pharmacoepidemiology
Online Access:https://doi.org/10.1002/epi4.13105
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items